Cell Therapy and Angiogenesis in Ischemic Pathology

Objectives

• Characterize ASCs (adipose stem cells) obtained from different tissues of individuals with various pathologies and determine their angiogenic capacity for use in cell therapy.
• Enhance the angiogenic capacity of ASCs through differentiation, genetic manipulation, and/or the use of their derivatives, such as microvesicles.

Research lines

• Cell Therapy: Use of ASCs as an angiogenic therapy in the treatment of ischemia.
• Endothelial Dysfunction and Cardiovascular Disease
• Tissue Factor and Angiogenesis

Group coordination

Civit Urgell, Anna IR
Garcia Garcia, Olaya IR
Serrano Lopez, Alejandro IR

Members